Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal-year 2025 second quarter ended December 31, 2024.
EPA has successfully added certain perfluoroalkyl substances (PFAS) to the toxic release inventory (TRI) list of chemicals ...
PEMGARDAâ„¢ (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 ...
Potential customers can visit the LungFit PH website, www.lungfitph.com, for additional information, including the product label, and to sign up for updates. About Beyond Air ®, Inc. Beyond Air is a ...
Ball Corporation's (NYSE: BALL) board of directors (the "Board") today declared a cash dividend of 20 cents per share, payable March 17, 2025, to shareholders of record as of March 3, 2025. In ...
Shareholders of UnitedHealth Group (UHG) are calling on the company’s board of directors to release ... authorization requirements or denials of coverage lead to delay or abandonment of medical ...
RAHWAY, N.J. - Merck & Co ., Inc. (NYSE:MRK) has received a positive recommendation from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for its pneumococcal ...
The Western Union Company ( NYSE: WU) Q4 2024 Results Conference Call February 4, 2025 4:30 PM ET Tom Hadley - Vice President of Investor Relations Devin McGranahan - Chief Executive Officer Matt ...
SAN DIEGO--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a Marketing Authorization ... Inc. This press release contains forward-looking ...
For more information, visit www.beyondair.net. Beyond Air’s LungFit is a cylinder-free, phasic flow generator and delivery system and has been designated as a medical device by the U.S. Food and ...
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.